PRTA Competitors & Alternatives
Compare Prothena Corporation plc with similar stocks in the same industry
Biotechnology
PRTA
Main Stock$8.15
Tradestie Score
51
Market Cap
$533.99M
Revenue Growth
17.1%
Analyst Upside
+162.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.95
|
$474.20M | 26.6 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.27
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.12
|
$463.20M | - | 49 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.36
|
$457.09M | - | 58 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.96
|
$454.29M | - | 60 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$19.19
|
$448.32M | - | 63 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$23.00
|
$422.50M | - | 64 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$59.17
|
$410.79M | - | 56 | Compare |
More PRTA Analysis
Data updated: Jun 16, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry